Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

NeuroMetrix Inc. buy melinda

Start price
€9.29
16.11.18 / 50%
Target price
€11.73
30.10.19
Performance (%)
-73.74%
End price
€2.44
30.10.19
Summary
This prediction ended on 30.10.19 with a price of €2.44. The BUY prediction by melinda for NeuroMetrix Inc. performed very badly with a performance of -73.74%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
NeuroMetrix Inc. - - - -
iShares Core DAX® -0.621% 1.080% 11.291% 16.439%
iShares Nasdaq 100 -4.503% -5.432% 22.172% 39.304%
iShares Nikkei 225® -2.562% -1.617% 7.262% 8.383%
iShares S&P 500 -1.706% -1.223% 22.550% 40.997%

Comments by melinda for this prediction

In the thread NeuroMetrix Inc. diskutieren
Prediction Buy
Perf. (%) -73.74%
Target price 1.173
Change
Ends at 30.10.19

SecteurEquipement, fournitures et distribution médicale



Métier
Designs and develops medical devices used for treatment of the neurological complications of diabetes

NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables.

It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder.

The company was founded by Shai N. Gozani in June 1996 and is headquartered in Waltham, MA.

Nombre d'employés : 41 personnes.



Prediction Buy
Perf. (%) -73.74%
Target price 1.173
Change
Ends at 30.10.19

Buy closed

Stopped prediction by melinda for NeuroMetrix Inc.

buy
NeuroMetrix Inc.

Start price
Target price
Perf. (%)
€13.63
05.02.18
€18.04
06.08.18
-19.93%
06.08.18

buy
NeuroMetrix Inc.

Start price
Target price
Perf. (%)
€37.16
01.05.17
€50.51
12.05.17
646.50%
12.05.17